This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $360,116.00 to the Regents of the University of Michigan to conduct research on "BRIEF PAIN REPROCESSING THERAPY: AN OPTIMIZED INTEGRATIVE EXPOSURE INTERVENTION FOR VETERANS WITH CHRONIC LOW BACK PAIN." The research project aims to develop and evaluate an innovative therapy to address chronic low back pain among veterans. The award has a...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $810,032 to Michigan State University to conduct research on neurobiological mechanisms to alleviate comorbid pain and obesity. The research will take place at Michigan State University's campus in East Lansing, Michigan and is expected to be completed by August 31, 2027. No details were provided on any sub-award recipients or services delivered under the grant.
The Defense Health Agency awarded a $553,588 Project Grant to Michigan State University on September 1, 2023 to conduct research on "NEUROBIOLOGICAL MECHANISMS TO ALLEVIATE COMORBID PAIN AND OBESITY." This Project Grant is funded through the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As the prime awardee, Michigan State University...
The University of Michigan will receive $780,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to conduct a mixed-methods study from September 2021 through August 2024. The study will examine the risk of Alzheimer's disease and related dementias among people with spinal cord injuries, comparing veterans and civilians. Through supporting innovative medical research, the Military Medical Research and Development program...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $374,999.00 to the University of South Florida to conduct research on the biomechanical and MRI-based outcomes of lumbar nonsurgical spinal decompression. The award period runs from Sept. 1, 2024 to Aug. 31, 2026. The University of South Florida, a major public research institution, will leverage its expertise in areas such as...
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
This Project Grant award of $2,037,497.00 from the Defense Health Agency was made to Michigan State University on September 30, 2023. The purpose of the grant is to transform behavioral health care to improve the quality of life for individuals with childhood-onset lupus. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public. As...
The Michigan State University was awarded a $704,249 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2021 to June 2024 to uncover mechanisms underlying cognitive changes and sleep in neurofibromatosis type 1 (NF1). The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $312,998.28 to Michigan State University to conduct a longitudinal study on the epidemiology of endometriosis after menopause. The research project will run from August 2024 to August 2026 and aims to advance scientific understanding of this condition in post-menopausal women, a population that has been underrepresented in prior endometriosis...
The University of Michigan will receive $304,472 over two years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research into regulating prostate skeletal bone metastases through TIM-3-dependent efferocytosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and...